Literatura académica sobre el tema "Bipolar II disorder"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Bipolar II disorder".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Bipolar II disorder"
Fawcett, Jan. "Bipolar II Disorder". Psychiatric Annals 26, n.º 7 (2 de julio de 1996): S440—S443. http://dx.doi.org/10.3928/0048-5713-19960702-06.
Texto completoBenazzi, Franco. "Bipolar II Disorder". CNS Drugs 21, n.º 9 (2007): 727–40. http://dx.doi.org/10.2165/00023210-200721090-00003.
Texto completoDunner, David L. "Bipolar II Disorder". Journal of Clinical Psychiatry 75, n.º 05 (15 de mayo de 2014): e465. http://dx.doi.org/10.4088/jcp.14bk09063.
Texto completoDunner, David L. "Bipolar II disorder". Bipolar Disorders 19, n.º 7 (noviembre de 2017): 520–21. http://dx.doi.org/10.1111/bdi.12567.
Texto completoTorrent, Carla, Anabel Martínez-Arán, Claire Daban, Jose Sánchez-Moreno, Mercè Comes, José Manuel Goikolea, Manel Salamero y Eduard Vieta. "Cognitive impairment in bipolar II disorder". British Journal of Psychiatry 189, n.º 3 (septiembre de 2006): 254–59. http://dx.doi.org/10.1192/bjp.bp.105.017269.
Texto completoParker, Gordon B., Mia Romano, Rebecca K. Graham y Tahlia Ricciardi. "Comparative familial aggregation of bipolar disorder in patients with bipolar I and bipolar II disorders". Australasian Psychiatry 26, n.º 4 (8 de mayo de 2018): 414–16. http://dx.doi.org/10.1177/1039856218772249.
Texto completoAdomaitiene, V., A. Kunigeliene, K. Dambrauskiene y V. Danileviciute. "Bipolar Affective Disorders: Diagnostic and Treatment Situation in Lithuania". European Psychiatry 24, S1 (enero de 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70790-4.
Texto completoParker, Gordon. "Highlighting Bipolar II Disorder". Canadian Journal of Psychiatry 49, n.º 12 (diciembre de 2004): 791–93. http://dx.doi.org/10.1177/070674370404901201.
Texto completoFedchenko, Viktoriya. "Early diagnosis of bipolar II disorder". Ukrains'kyi Visnyk Psykhonevrolohii, Volume 28, issue 4 (105) (29 de diciembre de 2020): 46–50. http://dx.doi.org/10.36927/2079-0325-v28-is4-2020-8.
Texto completoTamam, Lut, Nurgul Ozpoyraz y Gonca Karatas. "Personality disorder comorbidity among patients with bipolar I disorder in remission". Acta Neuropsychiatrica 16, n.º 3 (junio de 2004): 175–80. http://dx.doi.org/10.1111/j.1601-5215.2004.00074.x.
Texto completoTesis sobre el tema "Bipolar II disorder"
Dires, Helen Daniel y Abdi Farhiyo Bashir. "Upplevelser av att leva med bipolär sjukdom : en litteraturöversikt". Thesis, Ersta Sköndal Bräcke högskola, Institutionen för vårdvetenskap, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:esh:diva-9023.
Texto completoBackground: Bipolar disorder is a state of mind the can shift between elevation and severe depression. The disease picture is in focus and is fundamental to diagnosing an individual with bipolar disorder.Treatment for bipolar disorder is primarily pharmacological, but psychotherapy is applied if necessary. Good cooperation between the patient, family members and the care team can help the patient to get better condition for recovery through treatment. Aim: The aim was to highlight adults' experiences of living with bipolar disorder. Method: A general literature review was carried out based on ten qualitative articles in the results. Results: An analysis of the results of the compiled scientific articles revealed five themes: losing and regaining control, impact on interpersonal relationships, impact on self-image / identity, experience of stigma and experience of medical treatment. People had difficulty controlling their behaviors and mood swings in bipolar disorder. The loss of control meant that they did actions that they would not do when they were symptom-free, which created feelings of shame and guilt. The disease also affected interpersonal relationships and led to loss of studies, jobs and identity. The manic episode was characterized by positive experiences, loss of control and ongoing embarrassment. The depressive episode was characterized by negative thoughts and feelings. Lifestyle changes and various methods were used in combination with medication to manage the disease. Conclusion: Bipolar disorder is a complex mental illness that creates great suffering for people who have the diagnosis. The symptoms are like a roller coaster and unpredictable, which creates difficulties to understand and manage the mood swings. Despite the challenges, it is possible to limit the extent of the disease and live with it and have a relatively good life with the help of different management strategies.
Chaves, Moysés de Paula Rodrigues. "Estudo clínico e epidemiológico das apresentações iniciais de pacientes com transtorno afetivo bipolar–tipo I e II". Universidade Federal de Goiás, 2013. http://repositorio.bc.ufg.br/tede/handle/tde/2913.
Texto completoMade available in DSpace on 2014-08-21T12:48:09Z (GMT). No. of bitstreams: 2 license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) DISSERTACAO MESTRADO MOYSES PRONTA (1) (1).pdf: 679547 bytes, checksum: cf4dd53c812b868e1a8d7ceb72f62419 (MD5) Previous issue date: 2013-09-30
There are several studies on the differential diagnosis of Bipolar Disorder (BD), however, further investigation with an emphasis on clinical phenotypes that inaugurate the disease is needed. The aims of this study are to identify the psychiatric disorders most frequently diagnosed before the definitive diagnosis of BD, the time until the correct diagnosis and compare BD I and II for the variables studied. We studied 259 patients with current diagnosis of BD according to the DSM- IV-TR, evaluated by the same psychiatrist. Early psychiatric signs and symptoms were identified through an interview with the patient and family members and were considered suggestive of an initial diagnosis that was coded according to the same diagnostic criteria. The authors analyzed data on patients' age at prodromes suggestive of initial psychiatric diagnosis and time delay to the actual diagnosis of BD. Comparisons were made between sex, schooling and type of BD. The mean age of patients was 41.6 years, with a predominance of adults (19-60 years), women (67.6%), as well as type II BD (68.3%). Patients were on average 24.6 years of age at initial diagnosis, 41.6 years in the diagnosis of BD and the mean time delay between these was 16.9 years. The most common initial diagnoses were depressive disorders (41.3%), anxiety (12.7%), ADHD (8.1%), disorders related to substance abuse (7.7%), somatoform disorders (6 9%), and psychosis (5.4%). BD can be considered a “great imitator” in modern psychiatry, since initial phenotypes can mimic other disorders. BD diagnosis is very delayed in Brazil.
Há diversos estudos sobre o diagnóstico diferencial do Transtorno Bipolar (TB), entretanto, investigações com ênfase nos fenótipos clínicos que inauguram a doença são escassos. Os objetivos deste estudo consistem em identificar as doenças psiquiátricas mais frequentemente diagnosticadas antes do diagnóstico definitivo de TB, assim como o intervalo de tempo até o mesmo; e comparar o pacientes com TB I e II quanto aos diagnósticos iniciais, escolaridade, sexo e faixa etária. Para tanto, estudamos 259 pacientes com diagnóstico atual de TB segundo os critérios do DSM-IV-TR, realizado por um mesmo psiquiatra. Através de entrevistas com o paciente e familiares, identificou-se retrospectivamente os sinais e sintomas precoces considerados sugestivos do primeiro diagnóstico psiquiátrico, segundo os mesmos critérios. Dados relativos à idade dos pacientes no diagnóstico inicial e tempo até o diagnóstico atual de TB foram analisados e comparações foram feitas entre sexo, escolaridade, faixa etária e tipo de TB. A média de idade encontrada foi de 41,6 anos, com predominância de adultos (19-60 anos), do gênero feminino (67,6%), com TB II(68,3%). Os pacientes tinham em média 24,6 anos de idade no diagnóstico inicial, 41,6 anos no diagnóstico de TB e o tempo médio de atraso diagnóstico foi de 16,9 anos. Os diagnósticos iniciais mais frequentemente encontrados foram: transtornos depressivos (41,3%), ansiosos (12,7%), TDAH (8,1%), transtornos relacionados ao abuso de substâncias psicoativas (7,7%), transtornos somatoformes (6,9%) e psicóticos (5,4%). O T pode ser considerado um “grande imitador” moderno da Psiquiatria, posto que fenótipos iniciais podem mimetizar outros transtornos. Há um atraso significativo no diagnóstico do TBno Brasil.
Bailey, Bridget Catherine. "Comparing Psychotherapy With and Without Medication in Treating Adults with Bipolar II Depression: A Post-hoc Analysis". The Ohio State University, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1593624227017954.
Texto completoSen, Paromita [Verfasser], Wolfgang [Akademischer Betreuer] Wurst, Wolfgang [Gutachter] Wurst y Mathias V. [Gutachter] Schmidt. "Effects of bipolar disorder-associated single nucleotide polymorphism on Adenylyl cyclase II protein function and on mouse behaviour / Paromita Sen ; Gutachter: Wolfgang Wurst, Mathias V. Schmidt ; Betreuer: Wolfgang Wurst". München : Universitätsbibliothek der TU München, 2020. http://d-nb.info/1236692225/34.
Texto completoMantere, Outi. "Recognition, comorbidity, and outcome of DSM-IV bipolar I and II disorders in psychiatric care". Helsinki University of Helsinki, 2007. http://urn.fi/URN:ISBN:978-951-740-694-9.
Texto completoTiivistelmäosa. - University of Helsinki, Faculty of Medicine, Institute of Clinical Medicine, Department of Psychiatry, Department of Mental Health and Alcohol Research, National Public Health Institute. Myös paperimuodossa (ISBN 978-951-740-693-2).
Chen, Hui-Chun y 陳惠君. "Clinical Characteristics Between Bipolar I and Bipolar II Disorder". Thesis, 2008. http://ndltd.ncl.edu.tw/handle/90498636154834884010.
Texto completo國立成功大學
行為醫學研究所
96
Background: Bipolar disorder (BD) is the most common psychiatric condition associated with suicide. However, related literature remains limited and findings are controversial. Despite past research standings, current theories regarding the prognosis are not as optimistic for the soft form of BD due to its intensely chronic depressive features. However, by far, the distinctions of bipolar subgroups, especially for bipolar II, have not been well studied in Asian populations, and the crucial factors related to clinical outcome are unclear. Method: Ninety-three patients (bipolar I: 48; bipolar II: 45) were prospectively followed over a 24 weeks period and evaluated in this study. We investigated the symptomatic severity, suicidal risk (the Adult Suicidal Ideation Questionnaire; ASIQ), insight of illness (the Mood Disorders Insight Scale, MDIS) and quality of life (the Short Form of World Health Organization Questionnaire on Quality of Life-Taiwan Version; WHOQOL-BREF TW) across the mood state of each recruited subject. The socio-demographic information, prescribed medications and the drug compliance were also recorded. Results: The results showed that bipolar II (BPII) patients have a longer duration of onset to treatment, more prominently mixed depression and residual depressive symptoms, higher ASIQ scores in the acute stage, poor psychological QoL and lower prescription during the follow up period than bipolar I patients (BPI). Through the multiple Linear Regression models, three specific illness variables (depression symptoms, ASIQ scores, and the type of BD) could strongly account for mental life satisfaction; the explainable variances were 43.6%. Conclusion: Overall, our results indicated that BPII disorder might be a more severe, chronic subtype, and with special malignancy in comparison with BPI. It is hoped that the present article will bring attention to the markedly impaired psychological QoL in BPII patients and that the specific illness variables relevant to BPI and BPII affecting the clinical outcome can be more clearly delineated in the future.
Hsiao, Yih-Lynn y 蕭逸琳. "Neuropsychological Functions in Patients with Bipolar I and Bipolar II Disorder". Thesis, 2009. http://ndltd.ncl.edu.tw/handle/48132659143259007772.
Texto completo國立成功大學
行為醫學研究所
97
Background The literature reports persistent cognitive impairments in patients with bipolar disorder even after prolonged remission. However, a majority of studies have focused only on bipolar I disorder (BP-I), primarily because bipolar II disorder (BP-II) is often underdiagnosed or misdiagnosed. More attention should be paid to the differences between BP-I and BP-II, especially the aspects of neuropsychological functioning. We examined the different neuropsychological functions in BP-I and BP-II patients and compared them with those of healthy controls. Methods The study included 67 patients with inter-episode bipolar disorder (BP-I: n = 30, BP-II: n = 37), and 22 healthy controls compared using a battery of neuropsychological tests that assessed memory, psychomotor speed and certain aspects of frontal executive function. Results The BP-I group performed poorly on verbal memory, psychomotor speed, and executive function compared to the BP-II and control groups. Both bipolar groups performed significantly less well than the control group on measures of working memory and psychomotor speed, while the BP-II group showed an intermediate level of performance in psychomotor speed compared to the BP-I and control groups. There was no difference between the groups on visual memory. Conclusions BP-I was characterized by reduced performance in verbal memory, working memory, psychomotor speed, and executive function, while BP-II showed a reduction only in working memory and psychomotor speed. Cognitive impairment existed in both subtypes of bipolar disorder, and was greater in BP-I patients. Rehabilitation interventions should take into account potential cognitive differences between these bipolar subtypes.
Hsin-IWu y 吳欣怡. "Neuropsychological Function in Bipolar II Disorder Comorbid with or without Anxiety Disorder". Thesis, 2011. http://ndltd.ncl.edu.tw/handle/66798784690707665870.
Texto completoYu-ShanWang y 王于珊. "Different Genes Impact on Bipolar II Disorder with and without Comorbid Anxiety Disorder". Thesis, 2012. http://ndltd.ncl.edu.tw/handle/83596357915338584949.
Texto completo國立成功大學
行為醫學研究所
100
Aim: The aim of this study was to clarify aldehyde dehydrogenase 2 (ALDH2) and dopamine D2 receptor (DRD2) genes for predisposition to Bipolar II disorder (BP-II) comorbid with and without anxiety disorders (AD). To specify phenotype of BP-II and to reduce heterogeneity in the etiology of BP-II might support that comorbid AD is a subtype of BP-II. Background: The presence of comorbidity compounds disability, complicates treatment, and appears to worse the prognosis of bipolar disorders (BP). The frequently comorbid conditions include substance use disorders and anxiety disorders (AD) (generalized anxiety disorder, social phobia, panic disorder, obsessive compulsive disorder, and post-traumatic stress disorder), but comorbid AD has been underrecognized and understudies. The dopaminergic system has been implicated in the pathogenesis of BP and AD. The genes involved in metabolizing dopamine and encoding dopamine receptors, such as the aldehyde dehydrogenase 2 (ALDH2) and dopamine D2 receptor (DRD2) genes may be important. In the past few decades, a number of studies have investigated the association of DRD2 gene with BP as well as AD, but the findings are controversial. However, the comorbidity rate of AD and BP was relatively lower in the Han Chinese population than in the Western population. It may be easier for us to clarify the association of the DRD2 and ALDH2 polymorphisms and the possible interactions in BP-II with and without AD. Method: The sample consisted of total 462 BP-II patients with Research Diagnostic Criteria for 2-day hypomania cutoff based on DSM-IV-TR. 335 subjects were BP-II without AD, 127 subjects were of BP-II with AD and 348 were healthy subjects as normal control. The diagnosis for each patient was made by an attending psychiatrist and confirmed by a clinical psychologist using the Chinese Version of the Modified Schedule of Affective Disorder and Schizophrenia-Lifetime (SADS-L) to screen their psychiatric conditions. The genotypes of the ALDH2 and DRD2 TaqIA polymorphisms were determined using polymerase chain reactions plus restriction fragment length polymorphism analysis. Results: Logistic regression analysis showed a statistically significant association between DRD2 Taq-I A1/A2 genotype and BP-II with AD (OR=2.231, P=0.021). Moreover, a significant interaction of the DRD2 Taq-I A1/A1 and the ALDH2*1*1 genotypes in BP-II without AD was revealed. (OR=5.623, P= 0.001) to compare with normal control. Conclusion: Our findings support the hypothesis that a unique genetic distinction between BP-II with and without AD, and suggest a novel association between DRD2 Taq-I A1/A2 genotype and BP-II with AD. Our study also provides further evidence that the ALDH2 and DRD2 genes interact in BP-II, particularly BP-II without AD.
Hsu, Min-hsien y 許民憲. "The different performances on verbal memory and executive functions in patients with Bipolar I and Bipolar II Disorder". Thesis, 2008. http://ndltd.ncl.edu.tw/handle/18795392116752770622.
Texto completo國立成功大學
行為醫學研究所
96
Background: Previous studies found that psychosocial and occupational dysfunctions during the remission period among patients with Bipolar Disorder (BP) were associated with neuropsychological impairments, especially pertaining to executive function and verbal memory disabilities. Clinically, Bipolar I Disorder (BP-I) and Bipolar II Disorder (BP-II) were the most severe and frequently observed subtypes. Due to their distinct pathological characteristics, rehabilitation and intervention programs should be designed accordingly on the basis of the subtypes’ neuropsychological weaknesses to achieve a better treatment outcome. Currently however, reference literatures were limited. Thus, the present study aimed to further examine the different neuropsychological functions in patients with BP-I and BP-II. Method: All subjects were recruited from National Cheng Kung University Hospital. The Schedule for Affective and Schizophrenia-Lifetime Chinese version (SADS-L) were assessed to confirm diagnoses. When the patients’ mood symptoms were stabilized neuropsychological tests were administered. Results: Sixty-three patients diagnosed with BP participated in this study. The results showed that BP-I patients performed significantly worse on the number of categories completed in the Wisconsin Card Sorting test and the recognition total score of Logical Memory II compared to patients with BP-II. Conclusion: Overall, our results indicated that BP-I patients had relatively poorer performances on verbal memory encoding and a greater tendency to forget faster than BP-II patients; in regards to abstractive reasoning, either strategy formulation or planning abilities were comparatively worse in BP-I patients. Thus, clinical practitioners should keep in mind the distinctive characteristics of the two BP subtypes when constructing treatment or rehabilitation programs.
Libros sobre el tema "Bipolar II disorder"
Parker, Gordon, ed. Bipolar II Disorder. Cambridge: Cambridge University Press, 2001. http://dx.doi.org/10.1017/cbo9780511544187.
Texto completoParker, Gordon, ed. Bipolar II Disorder. Cambridge: Cambridge University Press, 2012. http://dx.doi.org/10.1017/cbo9781139003315.
Texto completoBipolar II disorder: Modelling, measuring and managing. 2a ed. Cambridge: Cambridge University Press, 2012.
Buscar texto completoBipolar II disorder: Modelling, measuring and managing. Cambridge: Cambridge University Press, 2009.
Buscar texto completoParker, Gordon, ed. Bipolar II Disorder. Cambridge University Press, 2018. http://dx.doi.org/10.1017/9781108333252.
Texto completoYatham, Lakshmi N. y Muralidharan Kesavan. The treatment of bipolar II disorder. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198748625.003.0009.
Texto completoParker, Gordon. Bipolar II Disorder: Modelling, Measuring and Managing. Cambridge University Press, 2019.
Buscar texto completoBipolar II disorder: Modelling, measuring, and managing. Cambridge: Cambridge University Press, 2008.
Buscar texto completoParker, Gordon y Kerrie Eyers. Bipolar II Disorder: Modelling, Measuring and Managing. Cambridge University Press, 2008.
Buscar texto completoParker, Gordon. Bipolar II Disorder: Modelling, Measuring and Managing. Cambridge University Press, 2012.
Buscar texto completoCapítulos de libros sobre el tema "Bipolar II disorder"
Parker, Gordon y Terence A. Ketter. "Management of Bipolar II Disorder". En Bipolar Disorder, 342–52. Chichester, UK: John Wiley & Sons, Ltd, 2010. http://dx.doi.org/10.1002/9780470661277.ch26.
Texto completoJudd, Lewis L. y Pamela J. Schettler. "The Long-Term Course and Clinical Management of Bipolar I and Bipolar II Disorders". En Bipolar Disorder, 17–30. Chichester, UK: John Wiley & Sons, Ltd, 2010. http://dx.doi.org/10.1002/9780470661277.ch3.
Texto completoVieta, Eduard. "Detection of bipolar II". En Guide to Assessment Scales in Bipolar Disorder, 17–21. Tarporley: Springer Healthcare Ltd., 2010. http://dx.doi.org/10.1007/978-1-907673-26-9_4.
Texto completoMagiria, Stamatia, Melina Siamouli, Xenia Gonda, Apostolos Iacovides y Konstantinos N. Fountoulakis. "Evidence Based Combination Therapy for Bipolar Disorder". En Polypharmacy in Psychiatry Practice, Volume II, 159–77. Dordrecht: Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-5799-8_9.
Texto completoGrunze, Heinz. "The Role of Polypharmacy in Bipolar Disorder Treatment Guidelines". En Polypharmacy in Psychiatry Practice, Volume II, 275–87. Dordrecht: Springer Netherlands, 2012. http://dx.doi.org/10.1007/978-94-007-5799-8_14.
Texto completoMoncrieff, Joanna. "The Medicalization of ‘Ups and Downs’: The Marketing of the New Bipolar Disorder". En De-Medicalizing Misery II, 105–19. London: Palgrave Macmillan UK, 2014. http://dx.doi.org/10.1057/9781137304667_7.
Texto completoParis, Joel y Adam Bayes. "Differentiating Bipolar II Disorder from Personality-based Dysregulation Disorders". En Bipolar II Disorder, 77–90. Cambridge University Press, 2019. http://dx.doi.org/10.1017/9781108333252.009.
Texto completoAiken, Chris B. "The Bipolar Spectrum". En Bipolar II Disorder, 16–32. Cambridge University Press, 2019. http://dx.doi.org/10.1017/9781108333252.004.
Texto completoParker, Gordon. "Mapping the Terrain of Bipolar II Disorder". En Bipolar II Disorder, 1–5. Cambridge University Press, 2019. http://dx.doi.org/10.1017/9781108333252.002.
Texto completoShorter, Edward. "Bipolar Disorder in Historical Perspective". En Bipolar II Disorder, 6–15. Cambridge University Press, 2019. http://dx.doi.org/10.1017/9781108333252.003.
Texto completoActas de conferencias sobre el tema "Bipolar II disorder"
Aminian, Ehsan y Saeed Setayeshi. "Fuzzy Logic Controller Applied to Brain Emotional Learning Based Model of Bipolar Disorder II". En 2015 3rd International Conference on Applied Computing and Information Technology/2nd International Conference on Computational Science and Intelligence (ACIT-CSI). IEEE, 2015. http://dx.doi.org/10.1109/acit-csi.2015.61.
Texto completo